Replies to post #31546 on Plandai Biotechnology Inc (PLPL)

[Aquahoya]

Two of us spoke to him a couple weeks ago at the latest. If he is buying shares back, this would in my opinion, be the time to do it

[zombywolf]

Again, 100:1. No more, no less.

[price_and_volume]

RS of AS is rare. Don't expect it.

OTCs RS the OS.

They typically leave the AS and preferred alone.

They'll be sure to leave themselves plenty of headroom in the share-structure for future issuance.